MedTrace Logo

Hemogram Parameter Changes With Sepsis Filter

NCT06948630 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2025-04-29

No results posted yet for this study

Summary

Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.

Conditions

  • Platelet Abnormality
  • Renal Failure
  • Immune System Disorder

Sponsors & Collaborators

  • Samsun University

    lead OTHER

Principal Investigators

  • Erkan Bayram · Istınye university faculity of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-02-01
Completion
2024-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06948630 on ClinicalTrials.gov